<SEC-DOCUMENT>0001193125-23-227040.txt : 20230901
<SEC-HEADER>0001193125-23-227040.hdr.sgml : 20230901
<ACCEPTANCE-DATETIME>20230901092557
ACCESSION NUMBER:		0001193125-23-227040
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230901
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230901
DATE AS OF CHANGE:		20230901

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMGEN INC
		CENTRAL INDEX KEY:			0000318154
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				953540776
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37702
		FILM NUMBER:		231230844

	BUSINESS ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320
		BUSINESS PHONE:		(805)447-1000

	MAIL ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMGEN
		DATE OF NAME CHANGE:	19870305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d525571d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amgn="http://www.amgen.com/20230901" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2023-09-01_to_2023-09-01" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-01_to_2023-09-01">0000318154</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2023-09-01_to_2023-09-01" name="dei:AmendmentFlag" contextRef="duration_2023-09-01_to_2023-09-01">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="amgn-20230901.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-01_to_2023-09-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-01</xbrli:startDate> <xbrli:endDate>2023-09-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-01</xbrli:startDate> <xbrli:endDate>2023-09-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A2.00SeniorNotesDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-01</xbrli:startDate> <xbrli:endDate>2023-09-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:2pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-01_to_2023-09-01">8-K</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-01_to_2023-09-01" format="ixt:date-monthname-day-year-en">September 1, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:EntityRegistrantName">Amgen Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:EntityFileNumber">001-37702</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:EntityTaxIdentificationNumber">95-3540776</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Identification No.)</span></td></tr> </table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-01_to_2023-09-01">One Amgen Center Drive</ix:nonNumeric><br /><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-01_to_2023-09-01">Thousand Oaks</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-01_to_2023-09-01" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-01_to_2023-09-01">91320-1799</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#x2019;s telephone number, including area code:</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(<ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:CityAreaCode">805</ix:nonNumeric>) <ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:LocalPhoneNumber">447-1000</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities Registered under Section 12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:Security12bTitle">Common Stock, $0.0001 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:TradingSymbol">AMGN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member" name="dei:Security12bTitle">2.000% Senior Notes Due 2026</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member" name="dei:TradingSymbol">AMGN26</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company <ix:nonNumeric contextRef="duration_2023-09-01_to_2023-09-01" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 1, 2023, Amgen Inc. (&#x201C;Amgen&#x201D;) and Horizon Therapeutics plc (&#x201C;Horizon&#x201D;) issued a joint press release related to Amgen&#x2019;s previously announced acquisition of Horizon (the &#x201C;Acquisition&#x201D;).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the joint press release regarding the information contained in this Item 7.01 issued by Amgen and Horizon on September 1, 2023 is attached hereto as Exhibit&#160;99.1 and is incorporated into this Item 7.01 by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in this Item 7.01 and Exhibit 99.1 shall not be deemed to be &#x201C;filed&#x201D; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934 (the &#x201C;Exchange Act&#x201D;), or otherwise subject to the liabilities of such section, nor will such information be deemed incorporated by reference in any filing under the&#160;Securities Act of 1933, as amended, or the&#160;Exchange Act, except as may be expressly set forth by specific reference in such filing.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 1, 2023, Amgen and Horizon announced the entry into a consent order agreement with the Federal Trade Commission (the &#x201C;FTC&#x201D;) that resolves the pending FTC administrative lawsuit related to the Acquisition.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the consent order agreement, Amgen and Horizon expect that the parties will jointly file stipulated proposed orders to dismiss the preliminary injunction motion and dissolve the temporary restraining order (TRO) in the U.S. District Court for the Northern District of Illinois, and that Amgen and Horizon will quickly seek the final approvals required under Irish law to close the Acquisition.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d525571dex991.htm">Press Release, dated September 1, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table> <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">-1-</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">AMGEN INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September 1, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/S/ Jonathan P. Graham</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Jonathan P. Graham</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and General Counsel and Secretary</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d525571dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g525571sp1a.jpg" ALT="LOGO">
</P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">One Amgen Center Drive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT STYLE="white-space:nowrap">Thousand&nbsp;Oaks,&nbsp;CA&nbsp;91320-1799</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Telephone <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1000</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:ARIAL">www.Amgen.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:46pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><B><I>News Release </I></B></P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:16pt; font-family:ARIAL" ALIGN="center"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">THOUSAND OAKS, Calif., &amp; DUBLIN (September 1,&nbsp;2023) &#150; Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the
entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen&#146;s acquisition of Horizon. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">As a result of the consent order agreement, Amgen and Horizon expect that the parties will jointly file stipulated proposed orders to dismiss the
preliminary injunction motion and dissolve the temporary restraining order (TRO) in the U.S. District Court for the Northern District of Illinois, and that Amgen and Horizon will quickly seek the final approvals required under Irish law to close the
acquisition. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Amgen has consistently stated to the FTC, the courts and the public that it has no reason, ability or intention to bundle Horizon&#146;s TEPEZZA&reg;
(terprotumumab-trbw) or KRYSTEXXA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (pegloticase injection) with any of its products. This narrow assurance, formalized in the consent order with the FTC, will have no impact on Amgen&#146;s
business. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">The companies anticipate being able to close the acquisition in early Q4 2023 and look forward to the opportunity to serve patients
around the world suffering from rare diseases. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>About Amgen </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically
improve people&#146;s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world&#146;s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines
with breakaway potential. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"><B></B>Page <FONT COLOR="#2b579a">
2</FONT>
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the
<FONT STYLE="white-space:nowrap">Nasdaq-100</FONT> index. In 2023, Amgen was named one of &#147;America&#146;s Greatest Workplaces&#148; by Newsweek and one of &#147;America&#146;s Climate Leaders&#148; by USA Today.</P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">For more information, visit <FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>Amgen.com</U></FONT><FONT STYLE="font-family:ARIAL"> and
follow us on </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>Twitter</U></FONT><FONT STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>LinkedIn</U></FONT><FONT
STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>Instagram</U></FONT><FONT STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>TikTok</U></FONT><FONT
STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>YouTube</U></FONT><FONT STYLE="font-family:ARIAL"> and </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>Threads</U></FONT><FONT
STYLE="font-family:ARIAL">.</FONT></P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>About Horizon </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Horizon is a global
biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people affected by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific
expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit <FONT
STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>HorizonTherapeutics.com</U></FONT><FONT STYLE="font-family:ARIAL"> and follow us on </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0070c0"><U>Twitter</U></FONT><FONT
STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0070c0"><U>LinkedIn</U></FONT><FONT STYLE="font-family:ARIAL">, </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0070c0"><U>Instagram</U></FONT><FONT
STYLE="font-family:ARIAL"> and </FONT><FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0070c0"><U>Facebook</U></FONT><FONT STYLE="font-family:ARIAL">. </FONT></P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="center">#&nbsp;#&nbsp;#</P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Amgen Forward-Looking Statements</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than
statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene,
Ltd. or Kyowa-Kirin Co., Ltd.), the performance of Otezla<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (apremilast) (including anticipated Otezla sales growth and the timing of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> EPS
accretion), the Teneobio, Inc. acquisition, the ChemoCentryx, Inc. acquisition, or the proposed acquisition of Horizon Therapeutics plc (including the potential outcome of any litigation with the Federal Trade Commission, prospective performance and
outlook of Horizon&#146;s business, performance and opportunities and any potential strategic benefits, synergies or opportunities expected as a result of such acquisition), as well as estimates of revenues, operating margins, capital expenditures,
cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health
problems on our business, outcomes, progress, and other such estimates and results.&nbsp;Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange
Commission reports filed by Amgen, including our most recent annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent periodic reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and current reports on Form <FONT
STYLE="white-space:nowrap">8-K.</FONT> Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a
result of new information, future events or otherwise. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"><B></B>Page <FONT COLOR="#2b579a">
3</FONT>
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">No forward-looking statement can be guaranteed and actual results may differ materially from those we
project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched
products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny
and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward
managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify
safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may
be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to
significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to
prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our
manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the
distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations.
We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our
marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product
is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices
and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product
similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other
companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic
benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not obtain regulatory clearance to acquire Horizon or be able to successfully
integrate Horizon, and such acquisition or integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality,
integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our
environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business.
Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are
favorable to us, or at all. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"><B></B>Page <FONT COLOR="#2b579a">
4</FONT>
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Horizon Forward-Looking Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are
often identified by words such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;see,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;can,&#148; &#147;may,&#148;
&#147;will,&#148; &#147;likely,&#148; &#147;depend,&#148; &#147;should,&#148; &#147;would,&#148; &#147;plan,&#148; &#147;predict,&#148; &#147;target,&#148; and similar expressions, and may include references to assumptions and relate to
Horizon&#146;s future prospects, developments and business strategies, and the acquisition of Horizon by Amgen. Such forward-looking statements include, but are not limited to, statements relating to the acquisition, the FTC litigation and
Horizon&#146;s and Amgen&#146;s expectations with respect to the timing of future events, including estimated timing of closing the acquisition. Horizon&#146;s expectations and beliefs regarding these matters may not materialize. Actual outcomes and
results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risks and uncertainties related to: whether and when the
district court enters an order dissolving the TRO; whether and when a new sanction hearing is scheduled by the Irish High Court; the ability of the parties to consummate the acquisition in a timely manner or at all; the satisfaction (or waiver) of
conditions to the consummation of the acquisition; the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the transaction agreement governing the acquisition; and the outcome of any
additional legal proceedings that have or may be instituted against the parties or any of their respective directors or officers related to the acquisition. Additional risks and uncertainties that could cause actual outcomes and results to differ
materially from those contemplated by the forward-looking statements are included under the caption &#147;Risk Factors&#148; and elsewhere in Horizon&#146;s most recent filings with the SEC, including its Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, and any subsequent reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC from time to
time and available at www.sec.gov. These documents can be accessed on Horizon&#146;s website at <FONT STYLE="white-space:nowrap">https://ir.horizontherapeutics.com/financial-information/sec-filings.</FONT> The forward-looking statements set out in
this news release are made only as of the date hereof. Horizon assumes no obligation and does not intend to update these forward-looking statements, except as required by law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"><B></B>Page <FONT COLOR="#2b579a">
5</FONT>
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Statements Required by the Irish Takeover Rules </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">The directors of Amgen accept responsibility for the information contained in this news release relating to Amgen and the Amgen Horizon Statements (as
defined below), except for the statements made by Horizon in respect of Amgen (the &#147;<B>Horizon Amgen Statements</B>&#148;).<B><I> </I></B>To the best of the knowledge and belief of the directors of Amgen (who have taken all reasonable care to
ensure such is the case), the information contained in this news release for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">The directors of Horizon accept responsibility for the information contained in this news release relating to Horizon and for the Horizon Amgen
Statements, except for the statements made by Amgen in respect of Horizon (the &#147;<B>Amgen Horizon Statements</B>&#148;).<B><I> </I></B>To the best of the knowledge and belief of the directors of Horizon (who have taken all reasonable care to
ensure that such is the case), the information contained in this news release for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Dealing Disclosure Requirements </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Under the provisions of Rule
8.3(b) of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022 (the &#147;<B>Irish</B> <B>Takeover</B> <B>Rules</B>&#148;), if any person is, or becomes, &#145;interested&#146; in 1% or more of any class of &#145;relevant securities&#146; of
Horizon, that person must publicly disclose all &#145;dealings&#146; in any &#145;relevant securities&#146; of Horizon during the &#145;offer period&#146;, by not later than 3:30 p.m. (E.T.) on the &#145;business day&#146; following the date of the
relevant transaction. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">If two or more persons <FONT STYLE="white-space:nowrap">co-operate</FONT> on the basis of any agreement either express or
tacit, either oral or written, to acquire an &#145;interest&#146; in &#145;relevant securities&#146; of Horizon or any securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">A disclosure table, giving details of the companies in whose &#145;relevant securities&#146; &#145;opening position&#146; and &#145;dealings&#146;
should be disclosed can be found on the Irish Takeover Panel&#146;s website at www.irishtakeoverpanel.ie. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">&#145;Interests&#146; in securities arise,
in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an &#145;interest&#146; by virtue of the ownership or control of
securities, or by virtue of any option in respect of, or derivative referenced to, securities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Terms in quotation marks are defined in the Irish
Takeover Rules, which can be found on the Irish Takeover Panel&#146;s website. If you are in any doubt as to whether or not you are required to disclose a &#145;dealing&#146; under Rule 8 of the Irish Takeover Rules, please consult the Irish
Takeover Panel&#146;s website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"><B></B>Page <FONT COLOR="#2b579a">
6</FONT>
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>General </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">A
copy of this news release will be available, free of charge (subject to certain restrictions relating to persons resident in certain restricted jurisdictions) on Amgen&#146;s website at
<FONT STYLE="white-space:nowrap">https://wwwext.amgen.com/horizon-offer</FONT> and on Horizon&#146;s website at https://ir.horizontherapeutics.com/information by no later than 12:00 noon (E.T.) on the business day following this news release and
throughout the course of the pending transaction. Neither the contents of Amgen&#146;s nor Horizon&#146;s websites nor the contents of any other website accessible from hyperlinks are incorporated into, or form part of, this statement. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="center">#&nbsp;#&nbsp;#</P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">AMGEN CONTACTS:&nbsp;Amgen,&nbsp;Thousand Oaks </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Jessica Akopyan, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-440-5721</FONT></FONT> (media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Justin Claeys, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-313-9775</FONT></FONT> (investors) </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">HORIZON CONTACTS: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Tina Ventura, <FONT
STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>Investor-relations@horizontherapeutics.com</U></FONT><FONT STYLE="font-family:ARIAL"> (investors) </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Geoff Curtis, <FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0070c0"><U>media@horizontherapeutics.com</U></FONT><FONT STYLE="font-family:ARIAL"> (U.S. media
contact) </FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Eimear Rigby, <FONT STYLE="font-family:ARIAL; font-size:11pt" COLOR="#0000ff"><U>media@horizontherapeutics.com</U></FONT><FONT
STYLE="font-family:ARIAL"> (Ireland media contact) </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>amgn-20230901.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 8/31/2023 7:12:11 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:amgn="http://www.amgen.com/20230901"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:us-types="http://fasb.org/us-types/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amgen.com/20230901"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20230901_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20230901_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20230901_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="amgn_A2.00SeniorNotesDue2026Member" name="A2.00SeniorNotesDue2026Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>amgn-20230901_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 8/31/2023 7:12:13 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20230901.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="amgn-20230901.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntitiesTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="17" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A2.00SeniorNotesDue2026Member" order="18" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="32.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="33.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="34.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="35.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>amgn-20230901_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 8/31/2023 7:12:12 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitiesTable" xlink:to="dei_EntitiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="amgn-20230901.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_A2.00SeniorNotesDue2026Member" xlink:to="amgn_A2.00SeniorNotesDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_A2.00SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">2.00% Senior Notes Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_A2.00SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2.00% Senior Notes Due 2026 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>amgn-20230901_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 8/31/2023 7:12:12 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20230901.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitiesTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_EntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="amgn-20230901.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A2.00SeniorNotesDue2026Member" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g525571sp1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g525571sp1a.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /;/M<_]_P#04 'VN?\ O_H* #[7/_?_ $% !]KG_O\ Z"@
M^US_ -_]!0 ?:Y_[_P"@H /M<_\ ?_04 'VN?^_^@H /M<_]_P#04 'VN?\
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MUP':% 'EGQ5U$R7]EIRM\L2&5P#W/ S] /UKZ#*:=HRJ/KH>'F=2\HP[&/\
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5 4 % !0 4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139739711034880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  01,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Amgen Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3540776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Amgen Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Thousand Oaks<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91320-1799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">447-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member', window );">2.00% Senior Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.000% Senior Notes Due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d525571d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:amgn="http://www.amgen.com/20230901"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amgn-20230901.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-01_to_2023-09-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A2.00SeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-01_to_2023-09-01"
      id="Hidden_dei_EntityCentralIndexKey_duration_2023-09-01_to_2023-09-01">0000318154</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2023-09-01_to_2023-09-01"
      id="Hidden_dei_AmendmentFlag_duration_2023-09-01_to_2023-09-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2023-09-01_to_2023-09-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-01_to_2023-09-01">2023-09-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-09-01_to_2023-09-01">Amgen Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-01_to_2023-09-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-01_to_2023-09-01">001-37702</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-01_to_2023-09-01">95-3540776</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-01_to_2023-09-01">One Amgen Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-01_to_2023-09-01">Thousand Oaks</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-01_to_2023-09-01">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-01_to_2023-09-01">91320-1799</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-01_to_2023-09-01">805</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-01_to_2023-09-01">447-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-01_to_2023-09-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-01_to_2023-09-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-01_to_2023-09-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-01_to_2023-09-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">AMGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">2.000% Senior Notes Due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">AMGN26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-01_to_2023-09-01_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-01_to_2023-09-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  [2R%7EXJ[',     3 @
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    "  [2R%7!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #M+(5<<V1R^[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( #M+(5>97)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ .TLA5P6EG^[%!   +A4  !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( #M+(5>?H!OPL0(  .(,   -              "  0D-  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ .TLA5Y>*NQS     $P(   L
M     ( !Y0\  %]R96QS+RYR96QS4$L! A0#%     @ .TLA5QPX9>H_ 0
M/ (   \              ( !SA   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( #M+(5<D'INBK0   /@!   :              "  3H2  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #M+(5=ED'F2&0$  ,\#
M   3              "  1\3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  &D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d525571d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d525571d8k.htm">d525571d8k.htm</File>
    <File>amgn-20230901.xsd</File>
    <File>amgn-20230901_def.xml</File>
    <File>amgn-20230901_lab.xml</File>
    <File>amgn-20230901_pre.xml</File>
    <File>d525571dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d525571d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "amgn-20230901_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d525571d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amgn-20230901_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amgn-20230901_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amgn-20230901.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "amgn",
   "nsuri": "http://www.amgen.com/20230901",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d525571d8k.htm",
      "contextRef": "duration_2023-09-01_to_2023-09-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d525571d8k.htm",
      "contextRef": "duration_2023-09-01_to_2023-09-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "amgn_A2.00SeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2.00% Senior Notes Due 2026 [Member]",
        "terseLabel": "2.00% Senior Notes Due 2026 [Member]"
       }
      }
     },
     "localname": "A2.00SeniorNotesDue2026Member",
     "nsuri": "http://www.amgen.com/20230901",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amgen.com//20230901/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-227040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-227040-xbrl.zip
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M6UUA*(:1-,ML^^V$7&=;WRGX^0U02P,$%     @ .TLA5VLR$Q.O!0  3#,
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MX11=.]]D'#>": *B(MEM:-U,YSJ$".()N"^S5(UO88 L:TMY-Z+AAJ,9L%;
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M"?J7,#3DUR5K EZ7T?NWNA N[-@&RE"W<X&(>7Q<<"UN!'^BS*]XC%ND\1J
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M+,H5]R+%FCA/2N"07E?K98AO[=_Q<);X<W7\O.SU1T,:!=;GM#?SFCJ4+3+
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M3Q[\G4SE%Z@_!8_ZZS[3133YTDNUY']02P,$%     @ /$LA5Q>$V%U>!0
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MER2OMFX@\/^ZO1F$4XAQA3##)]QI2JN)U+/UIKC/_NJDK2])4Z:>;GB8IKY
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MER?=HG-GSZ8GP/0_T-.M=+??/+(D[L?CXG?/0QX<07DH!(O4G1V=G6BZ4LY
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MWA-Z5F9OVXM/R ;BKWELPY$3B,C^ :\;T4NC$@TGV-@N6U9G-< Y:$I%[)C
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M)HJ!*5H20T4%5HE&2,J]^5VJT\WWW>ZER^Y.+Z^QV@)NBDH!O+X^L$)#K!%
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M, (@3#!?*:F\N@OD'7;4/@+M]7&YWI&.N$9IN4/8[ (0".+F1?3*%"/0V=_
M?Y>6P0=IVY,'[FQYJPPPMV DO'')1*,OL@W&-%OI&KT1/CCK9#CR7L9CXJYM
MK7%W08N@I7V9D'< S^P0!D.6@L(]%[JXS!;,30<UO*R[X@PO_<%%750D!;FU
MK$/?>TQ$LR^MU:M$P2++" >P5,A@C!Y!A; );>/.-W=]61M4%007^D!,Q]R*
MCV_!SZF/D88%7\\@R+/B2/8: GL]AMN8_M7%X?Q # >Y4@@BT'SV&U0 J\!E
M4B<(?%O%!SS;3+=F'+8C6__J#X(%4E#-B4OE6S<(2)0?1;A[FF(>XP))'M:
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=.3DQ+FAT;5!+!08     !@ & (,!  ##1@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
